Status:
UNKNOWN
Hand Sanitizer Use for Herpes Simplex Virus-1
Lead Sponsor:
Leciel Bono
Conditions:
Virus
HSV-1
Eligibility:
All Genders
18-99 years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this pilot study is to determine if the use of Purell hand sanitizer alters the duration, level of pain and discomfort during treatment, and the size of the HSV-1 lesion. The duration o...
Detailed Description
The participants will be divided into a control group (10 participants) and treatment group (10 participants) and will be given either the Purell hand sanitizer (treatment group) or medical grade mine...
Eligibility Criteria
Inclusion
- For the purpose of this study participants must be:
- in the early prodromal stage of an HSV-1 outbreak (less than 24 hours from initial symptom)
- have a visible manifestation of a lesion
- be 18 years or older
- capable of following daily treatment instructions
- willing to complete a daily journal
- willing to come to the clinic twice for records and pictures during the14 days that the lesion is present or until participant is free of lesion.
Exclusion
- For the purpose of this study participants cannot:
- be immunocompromised
- be pregnant
- have taken any antiviral medication within the last two weeks
- have used any creams in the last ten days.
Key Trial Info
Start Date :
April 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06135844
Start Date
April 8 2022
End Date
November 30 2023
Last Update
November 18 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Idaho State University
Pocatello, Idaho, United States, 83209
2
Cotton Creek Dental
St. George, Utah, United States, 84780
3
Utah Tech University
St. George, Utah, United States, 84790